Inventor
INGLESE JAMES
US21 patents
⚠️ This page may combine multiple inventors who share the name “INGLESE JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
7 patentsUS11324725B2May 10, 2022
Compositions and methods for the inhibition of pruritus
US HEALTH0 citations55
US9707230B2Jul 18, 2017
Activators of human pyruvate kinase
US HEALTH0 citations49
US9290512B2Mar 22, 2016
Activators of human pyruvate kinase
US HEALTH0 citations49
US9458141B2Oct 4, 2016
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
US HEALTH0 citations48
US9296729B2Mar 29, 2016
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
US HEALTH0 citations48
US9187457B2Nov 17, 2015
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
US HEALTH0 citations48
US10808010B2Oct 20, 2020
Peptide inhibitors of phosphoglycerate mutase and methods of use
US HEALTH0 citations46
PHARMACOPEIA INC
4 patentsUS5876946AMar 2, 1999
High-throughput assay
PHARMACOPEIA INC213 citations97
US6335176B1Jan 1, 2002
Incorporation of phosphorylation sites
PHARMACOPEIA INC98 citations95
US6406869B1Jun 18, 2002
Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents
PHARMACOPEIA INC35 citations89
US6156520ADec 5, 2000
Site-specific bioconjugates of chemokines and their use in assays
PHARMACOPEIA INC20 citations86
PHARMACOPEIA DRUG DISCOVERY
3 patentsUS6943161B2Sep 13, 2005
Pyrimidine and triazine kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY7 citations71
US7037916B2May 2, 2006
Pyrimidine derivatives as IL-8 receptor antagonists
PHARMACOPEIA DRUG DISCOVERY3 citations61
US6806056B2Oct 19, 2004
Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agent
PHARMACOPEIA DRUG DISCOVERY5 citations59